Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar ARBinEXILEman (25.72) Submitted: 2/21/2007 10:43:18 PM : Outperform Start Price: $13.52 CBLI Score: -86.39

buy buy buy

Featured Broker Partners


Advertisement